<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html><head>
<!-- Google tag (gtag.js) -->

  <script async="" src="https://www.googletagmanager.com/gtag/js?id=G-JV5XCN591D"></script>

  <script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-JV5XCN591D');
  </script>

  <meta name="AUTHOR" content="Farasat Bokhari">


  <meta name="GENERATOR" content="Microsoft FrontPage 4.0">
  <title>Research and Papers</title>


<!-- Author of web site: Farasat Bokhari-->
</head><body>
<h3>Research Summary </h3>

My research falls into two overlapping areas: (i) industrial
organization and competition economics (mostly
applied to the health sector. i.e., hospitals, pharmaceuticals, etc.
but not exclusively), and (ii) health outcomes and health policies. The
latter also spill into issues of education, gender, and racial equity.
<p>Some of my recent work in pharmaceuticals focuses on firm strategies
and how they impact consumer welfare, firm profits, and growth. I have
worked on the valuation/welfare effects of introducing generics and <a href="../papers/bf2008-1v5.pdf">second-generation (`me-too') drugs</a>
in a product market, the <a href="../papers/bbm2014-1-v04e.pdf">impact
of additional presentations on the growth</a> of a business unit, and
now more recently on <a href="../papers/by2019-1-v03b.pdf">entry
deterring effects of presentation proliferation and of product hopping</a>.&nbsp;
I have also worked on <a href="../papers/bmp2014-1-v04f.pdf">pay-for-delay
deals in the European and American</a> legal contexts and the <a href="../papers/b2012-2v02.pdf">cost</a> of such (anticompetitive)
deals. One of the _blank contributions of this work is the policy
simulations that show which legislative changes are likely to make
anti-competitive deals not possible and which might make the situation
worse.</p>

<p>
</p>

<p> Concurrently, I am also working on policies to address the rise of <a href="../papers/bmy2017-1-v02b.pdf">antibacterial resistance</a> via
managing the demand for broad- vs narrow-spectrum antibiotics.&nbsp; I
also have current work on evaluating alcohol regulations such as a <a href="../papers/bdms2019-1-v02a.pdf">ban on non-linear pricing</a> or
establishing <a href="../papers/bcdm2021-1-v01h.pdf">price floors</a>
to curb excessive alcohol consumption and its heterogenous impact. <br>
</p>

<h3>Working papers/work in progress</h3>

<ul>
<u><b>Under revision with R&Rs</b></u><br><br>

  <li><a href="bmy2017-1-v02b.pdf">"Antibiotic consumption in the UK and the cost of shifting demand
away from broad-spectrum drugs"</a> (with Franco Mariuzzo and Weijie Yan).
R&amp; Fall 2023. R at <em>International Journal of
Industrial Organization.</em><br>
    <br>
  </li>

 <li><a href="bemo2022-1-v01a.pdf">"Do the poor pay disproportionately more for increasing market
concentration? A study of retail petroleum markets"</a> (with Sean Ennis,
Franco Mariuzzo, and Peter Ormosi). March 2022. R&amp;R at <em>Journal of
Industrial Economics.</em><br>
    <br>
</li>

 <li><a href="by2019-1-v03e.pdf">"Proliferation and entry deterrence"</a> (with Weijie Yan). Spring 2023. R&amp;R at <em>Journal of Economics and Management Strategy</em> &nbsp;<br>
    <br>
</li>


  <u><b>In preperation</b></u><br><br>


  <li>"Merger review using online experiments'' (with Stefan Penczynski and
Janithe Siriwardana).&nbsp; In preparation. (Download <a href="bps2022-1-v02slides.pdf">latest slides </a> from here.)<br>
    <br>
  </li>

<li>"Retrospective merger evaluation: GSK-Pfizer consumer health in
    Philippines''  (tentative title) </a> (with Sean Ennis, Carlos Vega and Weijie Yan). In
    preparation. (Download <a href="bevy2022_01-v01b-slides.pdf">latest slides </a> from here.)<br>
    <br>
  </li>

   </li>
  <li>"Medicine procurement with dynamic reserve price mechanism''
    (tentative title) </a> (with Sean Ennis, Carlos Vega and Tim Salmon). In
    preparation.<br>
    <br>
  </li>


  <li>"Dynamic reserve prices in procurement auctions: An Experiment''  (tentative title) </a> (with Sean Ennis, Carlos Vega and Tim Salmon). In preparation.<br>
    <br>
  </li>


<li>"Residential preferences for social interactions: slum formation in nineteenth and twentieth century
Dublin" (with Silvi K. Berger and Franco Mariuzzo). In preparation.    <br>
  </li>




</ul>


<h3 align="left">Accepted  </h3>
<ul>

<li><a href="abb2018_1v6.5.pdf">"Discrimination in healthcare: A field experiment with Pakistan's
Transgender community"</a> &nbsp; (with Husnain F. Ahmad and Sheheryar
Banuri).&nbsp;December 2023. Accepted at <em>Labour Economics.</em> &nbsp;<br>
<br>
</li>

   <li><a href="bcdm2021-1-v02a.pdf">"Lockdown drinking: the sobering effect of alcohol minimum pricing"</a> (with Ratula Chakraborty, Paul W. Dobson and Marcello Marciano). Fall 2023.  Conditionally accepted at <em> Economic Inquiry.</em> <br>
    <br>
  </li>


</ul>


<h3 align="left">Publications </h3>

<ul>





  <li><a href="https://doi.org/10.1016/j.euroecorev.2023.104480" target="_blank"> "Banning volume discounts to curb excessive consumption: A
cautionary tale"</a> (with Paul Dobson, Marcello Morciano, and Marc
Suhrcke).&nbsp; <span style="font-style: italic;">European Economic Review</span> 156-104480. July 2023.
(Download <a href="bdms2019-1-v02a.pdf">latest wp-version</a> from
here.)<br>
    <br>
  </li>
  <li><a href="https://doi.org/10.1007/s11187-019-00307-w" target="_blank">"Innovation and growth in the UK pharmaceuticals: the
case of product and marketing introductions</a>" (with Franco Mariuzzo
and Ann Rita Bennato). <span style="font-style: italic;">Small
Business Economics</span>, 57(1) 603-634. 2021. (Download <a href="bbm2014-1-v04e.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li>"<a target="_blank" href="https://doi.org/10.1111/jems.12351" target ="_blank">Entry
limiting agreements for pharmaceuticals: pay-to-delay and authorized
generic deals</a>'' (with Franco Mariuzzo and Arnold Polanski). <span style="font-style: italic;">Journal of Economics and Management
Strategy</span>, 29(3) 516-542, Fall 2020. (Download&nbsp; <a href="bmp2014-1-v04f.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li>"<a href="https://doi.org/10.1016/j.ijindorg.2018.01.005" target="_blank">Demand estimation and merger simulations for drugs:
Logits v. AIDS</a>" (with Franco Mariuzzo). <span style="font-style: italic;">International Journal of Industrial
Organization</span>, 61 (November), 653-685, 2018. (Download <a href="b2012-1v02c.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li><a href="https://doi.org/10.1002/psb.1563" target="_blank">Can
drug price hikes via debranding be prevented?</a>" (with Bruce Lyons). <em>Prescriber</em>,
28(4), 44-46, April, 2017. (Download <a href="bl2017-1-v04.pdf">last
wp-version</a> from here.) </li>
  <br>
  <li>"<a href="https://doi.org/10.1186/2191-1991-4-1" target="_blank">Selective
admission into stroke unit and patient outcomes: a tale of four cities</a>"
(with I Wellwood, A Rudd, P Langhorne, M
Dennis and CWolfe). <span style="font-style: italic;">Health Economics
Review</span>,
4(1), 1-10, 2013. (Download <a href="bww2011-1v16.pdf">last wp-version</a>
from here.)<br>
    <br>
  </li>
  <li>"<a href="https://doi.org/10.1093/joclec/nht016" target="_blank">What
is the price of pay-to-delay deals?</a>" <span style="font-style: italic;">Journal of Competition Law and Economics</span>,
9(3), 739-753, 2013. (Download <a href="b2012-2v02.pdf">last wp-version</a>
from here.)<br>
    <br>
  </li>
  <li>"<a target="_blank" href="https://doi.org/10.1111/joie.12017">Entry
in the ADHD drugs market: Welfare impact of generics and me-toos</a>"
(with Gary Fournier). <span style="font-style: italic;">Journal of
Industrial Economics</span>, 61(2), 339-392, 2013. (Download <a href="bf2008-1v5.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li>"<a href="https://doi.org/10.1016/j.jhealeco.2011.01.007" target="_blank">School accountability laws and consumption of
psychostimulants</a>" (with Helen Schneider). <span style="font-style: italic;">Journal of Health Economics</span>, 30(2),
355-372, 2011. (Download <a href="bs2009-1v8.pdf">last wp-version</a>
from here.)<br>
    <br>
  </li>
  <li>"<a href="https://doi.org/10.1016/j.ijindorg.2008.08.001" target="_blank">Managed care and the adoption of technology: The case
of cardiac catheterization</a>". <span style="font-style: italic;">International
Journal of Industrial Organization</span>, 27(2), 223-237, March, 2009.
(Download <a href="b2000_1v8b.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li>"<a href="https://doi.org/10.1007/s10742-008-0035-x" target="_blank">Risk factors for discontinuing drug therapy among
children with ADHD</a>" (with Frank Heiland, Peter Levine and Tom Ray).
    <span style="font-style: italic;">Health Services and Outcomes
Research Methodology</span>, 8(3), 134-158, September, 2008. (Download <a href="bhlr2007-1.v2a.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li>"<a href="https://doi.org/10.1111/j.1467-6451.2007.00321.x" target="_blank">Open versus closed firms and the dynamics of industry
evolution</a>" (with Ashish Arora). <span style="font-style: italic;">Journal
of Industrial Economics</span>, 55(3) 499-527, September, 2007.
(Download <a href="ab961-v2006july.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li>"<a target="_blank" href="https://doi.org/10.1002/hec.1157">Government
health expenditures and health outcomes</a>" (with Yunwei Gai and Pablo
Gottret). <span style="font-style: italic;">Health
Economics</span>, 16(3),257-273, March, 2007. (Download <a href="bgg2005_1v3d.pdf">last wp-version</a> from here.)<br>
    <br>
  </li>
  <li><a target="_blank" href="https://doi.org/10.1001/archpedi.160.10.1063">"Attention-deficit/hyperactivity
disorder in children: Excess costs before and after initial diagnosis
and treatment</a>" (with Tom Ray, Peter Levine, Lisa Croen, Teh-wei Hu
and Laurel Habel). <span style="font-style: italic;">Archives of
Pediatrics &amp; Adolescent Medicine</span>, 160(10), 1063-1069, 2006. <br>
    <br>
  </li>
  <li>"<a target="_blank" href="https://doi.org/10.1002/pds.980">An
analysis of the significant variation in psychostimulant use across the
U.S.</a>" (with Rick Mayes and Richard Scheffler). <span style="font-style: italic;">Journal of Pharmacoepidemiology and Drug
Safety</span>, 14(4), 267-275,
2005.</li>
</ul>

<h5>Reports and Chapters </h5>

<ul>

  <li>"<a target="_blank" href="https://doi.org/10.1142/9789813272378_0001">Assessing the impact
of health care expenditures on mortality using cross-country data</a>"
(with Ryota Nakamura, James Lomas, Karl Claxton, Rodrigo Moreno-Serra,
and Marc Suhrcke) in Global Health Economics: Shaping Health Policy In
Low- And Middle-income Countries 2020. World Scientific Publishing Co.
Ltd, pp.3-49. (Download <a href="nlcbss2016-v03.pdf">last wp-version</a>
from here.)<br>
    <br>
  </li>
  <li>"<a target="_blank" href="https://tinyurl.com/y6a6fnpj">Evaluating
wholesale and retail mergers in pharmaceuticals</a>" (with Franco
Mariuzzo).&nbsp; OECD's Global Forum on Competition,
DAF/COMP/GF(2014)4, February, 2014. (Download <a href="bm2014-2v01.pdf">last
wp-version</a> from here.)<br>
    <br>
  </li>
  <li>"<a target="_blank" href="http://hdl.handle.net/10986/7094">Improving
health outcomes</a>" (with Yunwei Gai and Pablo Gottret) in Health
Financing Revisited: A Practitioner's Guide by Pablo Gottret and George
Schieber. World Bank, Washington, D.C., 2006. (Download <a href="bokhari2006a.pdf">last wp-version</a> from here.) </li>
</ul>

<h5>Retired papers</h5>

<ul>

  <li> <a target="_black" href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=192828">"Does
Managed care matter? Hospital utilization in the U.S. between 1985 and
1993"</a> (with Jon Caulkins, Martin Gaynor and Doug Wholey). Paper
retired. <br>
    <br>
  </li>
  <li> Optimum population: A new look -- A Hamiltonian approach towards
a dynamic analysis (with George McCarthy). Paper retired. <br>
    <br>
  </li>
</ul>

<hr>
<p align="center"><font color="#800000"><strong><small><em>This page
was last updated on Oct/24/2023 </em></small></strong></font></p>

</body></html>
